CYR61 has distinct expression profiles for three non-small lung cancer (NSCLC) cell lines (H1155, H460, and H2122), five colorectal cancer cell lines (SW837, SW620, HT-29, HCA-7, and HCT116), one breast cancer cell line (MCF-7), and one esophageal squamous carcinoma cell line (TE-7) with enhanced expression of the αvβ5 integrin [11]. This evidence concerns the gene CCN1 and non-small cell lung carcinoma.